EVALUATION OF CK-19 BIOMARKER IN THE PERIPHERAL BLOOD OF BREAST CANCER PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

OLOOMI M.; BOUZARI S.; RASAEIAN A.; MOHAGHEGHI M.A.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Surgery Year:2011 | Volume:19 | Issue:1 Page(s): 9-15

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

2,658

Download:

Cites:

Information Journal Paper

Title

EVALUATION OF CK-19 BIOMARKER IN THE PERIPHERAL BLOOD OF BREAST CANCER PATIENTS

Author(s)

OLOOMI M. | BOUZARI S. | RASAEIAN A. | MOHAGHEGHI M.A. | Issue Writer Certificate

Keywords

BREAST CANCERQ3

BIOMARKERQ3

Abstract

Introduction & Objective: BREAST CANCER is one of the main causes of cancer-related mortality, resulting in approximately 40,000 to 50, 000 deaths annually. BREAST CANCER is the most prevalent cancer in Iran and in the world, but the epidemiological aspects of Iranian BREAST CANCER is uncertain. Early diagnosis of cancer cells in the peripheral blood is a critical determinant for proper treatment. In spite of the heterogeneity of BREAST CANCER at the molecular level, circulating tumor cells (CTCs) may provide a novel marker. On the other hand, approximately 20-40% of BREAST CANCER patients have shown detectable Cytokeratin 19 (CK19).Materials & Methods: In the present study, the RNA of blood cells of 60 samples (30 patients and 30 normal) was extracted. The RT-PCR technique was applied to the extracted RNA, using specific primers. CK19 expression was evaluated by statistical chi-square test.Results: Cytokeratin-19 was found to be present in the blood of all the patients. However, normal samples were divided in two groups: a) with cytokeratin expression b) without cytokeratin expression. Cytokeratin expression was related with history of cancer in their family.Conclusions: Investigation on the presence of Cytokeratin-19 BIOMARKER in the early stages of disease could be a suitable prognostic factor in blood of the patients. Study on a larger number of patients with more BIOMARKERs with the predictive and/or prognostic value should be considered in the future studies.

Cites

No record.

References

No record.

Cite

APA: Copy

OLOOMI, M., BOUZARI, S., RASAEIAN, A., & MOHAGHEGHI, M.A.. (2011). EVALUATION OF CK-19 BIOMARKER IN THE PERIPHERAL BLOOD OF BREAST CANCER PATIENTS. IRANIAN JOURNAL OF SURGERY, 19(1), 9-15. SID. https://sid.ir/paper/112774/en

Vancouver: Copy

OLOOMI M., BOUZARI S., RASAEIAN A., MOHAGHEGHI M.A.. EVALUATION OF CK-19 BIOMARKER IN THE PERIPHERAL BLOOD OF BREAST CANCER PATIENTS. IRANIAN JOURNAL OF SURGERY[Internet]. 2011;19(1):9-15. Available from: https://sid.ir/paper/112774/en

IEEE: Copy

M. OLOOMI, S. BOUZARI, A. RASAEIAN, and M.A. MOHAGHEGHI, “EVALUATION OF CK-19 BIOMARKER IN THE PERIPHERAL BLOOD OF BREAST CANCER PATIENTS,” IRANIAN JOURNAL OF SURGERY, vol. 19, no. 1, pp. 9–15, 2011, [Online]. Available: https://sid.ir/paper/112774/en

Related Journal Papers